NO922022L - Polykondensater som inneholder vinsyrederivater, fremgangsmaate for fremstilling av disse og anvendelse av dem - Google Patents

Polykondensater som inneholder vinsyrederivater, fremgangsmaate for fremstilling av disse og anvendelse av dem

Info

Publication number
NO922022L
NO922022L NO92922022A NO922022A NO922022L NO 922022 L NO922022 L NO 922022L NO 92922022 A NO92922022 A NO 92922022A NO 922022 A NO922022 A NO 922022A NO 922022 L NO922022 L NO 922022L
Authority
NO
Norway
Prior art keywords
tinaric
procedure
preparation
acid derivatives
polycondensates containing
Prior art date
Application number
NO92922022A
Other languages
English (en)
Other versions
NO922022D0 (no
NO302372B1 (no
Inventor
Volker Krone
Michael Magerstaedt
Axel Walch
Paul-Gerhard Kibat
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO922022D0 publication Critical patent/NO922022D0/no
Publication of NO922022L publication Critical patent/NO922022L/no
Publication of NO302372B1 publication Critical patent/NO302372B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66—Polyesters containing oxygen in the form of ether groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/225—Microparticles, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2045—Polyamides; Polyaminoacids, e.g. polylysine
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/12—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from polycarboxylic acids and polyhydroxy compounds
    • C08G63/16—Dicarboxylic acids and dihydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/60—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from the reaction of a mixture of hydroxy carboxylic acids, polycarboxylic acids and polyhydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/26—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from polyamines and polycarboxylic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyamides (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Polyesters Or Polycarbonates (AREA)
NO922022A 1991-05-24 1992-05-22 Polykondensater som inneholder vinsyrederivater og anvendelse av disse, til fremstilling av ultralydkontrastmidler og depot-tilberedninger av virksomt stoff samt terapeutika og diagnostika inneholdende ultralydkontrastmiddelet NO302372B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4116936 1991-05-24

Publications (3)

Publication Number Publication Date
NO922022D0 NO922022D0 (no) 1992-05-22
NO922022L true NO922022L (no) 1992-11-25
NO302372B1 NO302372B1 (no) 1998-02-23

Family

ID=6432312

Family Applications (1)

Application Number Title Priority Date Filing Date
NO922022A NO302372B1 (no) 1991-05-24 1992-05-22 Polykondensater som inneholder vinsyrederivater og anvendelse av disse, til fremstilling av ultralydkontrastmidler og depot-tilberedninger av virksomt stoff samt terapeutika og diagnostika inneholdende ultralydkontrastmiddelet

Country Status (6)

Country Link
US (3) US5391696A (no)
EP (1) EP0514790A2 (no)
JP (1) JPH05178971A (no)
CA (1) CA2069459A1 (no)
IE (1) IE921659A1 (no)
NO (1) NO302372B1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9206736D0 (en) * 1992-03-27 1992-05-13 Sandoz Ltd Improvements of organic compounds and their use in pharmaceutical compositions
DE4407898A1 (de) * 1994-03-09 1995-09-14 Hoechst Ag Nanopartikel, enthaltend einen Wirkstoff und ein Polyketalweinsäureamid, Verfahren zu ihrer Herstellung und Verwendung derselben
DE19809913A1 (de) * 1998-03-07 1999-09-09 Aventis Res & Tech Gmbh & Co Biodegradable Polymere auf der Basis von natürlichen und nachwachsenden Rohstoffen insbesondere Isosorbit
US6342300B1 (en) 1999-02-20 2002-01-29 Celanese Ventures Gmbh Biodegradable polymers based on natural and renewable raw materials especially isosorbite
DE10053267B4 (de) * 2000-10-26 2005-12-22 Celanese Ventures Gmbh Verfahren zur Herstellung von mikrosphärischen Kristalliten, danach hergestellte mikrosphärische Kristallite und deren Verwendung
AU2003235708A1 (en) * 2002-01-16 2003-07-30 Akzo Nobel N.V. Polytartrate composition
JP4881127B2 (ja) 2005-11-07 2012-02-22 キヤノン株式会社 高分子化合物およびその合成方法
JP5120944B2 (ja) * 2008-04-25 2013-01-16 独立行政法人産業技術総合研究所 生分解性高分子量脂肪族ポリエステルおよびその製造方法
WO2010033586A2 (en) * 2008-09-16 2010-03-25 Ecolab Inc. Use of hydroxycarboxylates for water hardness control
EP2246472A1 (en) 2009-03-24 2010-11-03 Mondi Limited South Africa Process for preparing polysaccharide gel particles and pulp furnish for use in paper making
JP5812791B2 (ja) * 2011-03-28 2015-11-17 キヤノン株式会社 プリンター、複写機
JP2013006963A (ja) * 2011-06-24 2013-01-10 Unitika Ltd ポリアミドおよびその成形体
JP5955205B2 (ja) * 2012-01-23 2016-07-20 キヤノン株式会社 薬品封止用フィルム

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3297033A (en) * 1963-10-31 1967-01-10 American Cyanamid Co Surgical sutures
DE1520194A1 (de) * 1964-05-08 1969-11-27 Kuehn Dr Phil Nat Habil Martin Verfahren zur Herstellung von hoehermolekularen Kondensationsprodukten aus drei- und mehrwertigen Alkoholen,dadurch gekennzeichnet,dass man mindestens zwei Hydroxylgruppen dieser Alkohole durch Acetal und/oder Ketalbildung blockiert und die restlichen Hydroxylgruppen durch Acetalisierung,Veraetherung oder
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
US3608063A (en) * 1969-08-15 1971-09-21 Gilbert S Banker Molecular drug entrapment process and compositions
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4180646A (en) * 1975-01-28 1979-12-25 Alza Corporation Novel orthoester polymers and orthocarbonate polymers
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
JPS5913534B2 (ja) * 1975-12-25 1984-03-30 ニホンパ−オキサイド カブシキガイシヤ ポリアミドカゴウブツノセイゾウホウ
JPS52147697A (en) * 1976-06-03 1977-12-08 Naoya Ogata Method of making polyamide
JPS5432594A (en) * 1977-08-16 1979-03-09 Mitsubishi Gas Chem Co Inc Polycondensate
JPS59159823A (ja) * 1983-02-28 1984-09-10 Kanegafuchi Chem Ind Co Ltd 耐熱性芳香族ポリエステルスルホンおよびその製造方法
JPH0743339B2 (ja) * 1987-07-09 1995-05-15 テルモ株式会社 イオンセンサ
AU635200B2 (en) * 1988-02-05 1993-03-18 Schering Aktiengesellschaft Berlin Und Bergkamen Ultrasonic contrast agents, process for producing them and their use as diagnostic and therapeutic agents
DE3837063C1 (no) * 1988-10-31 1990-03-29 Reimar Dr. 8000 Muenchen De Lenz
DE3936191C2 (de) * 1989-10-31 1996-10-17 Boehringer Ingelheim Kg Neue Copolymere aus Milchsäure und Weinsäure, ihre Herstellung sowie ihre Verwendung
US5106936A (en) * 1990-06-08 1992-04-21 The Dow Chemical Company Thermoplastic compositions with nonlinear optical activity
US5073176A (en) * 1990-11-05 1991-12-17 E. I. Du Pont De Nemours And Company Dicarboxylic acid polyesters and polyamides for fluid separation membranes
US5136018A (en) * 1990-11-19 1992-08-04 General Electric Company Macrocyclic polyarylate compositions of decreased crystallinity

Also Published As

Publication number Publication date
IE921659A1 (en) 1992-12-02
EP0514790A3 (no) 1994-03-30
US5391696A (en) 1995-02-21
NO922022D0 (no) 1992-05-22
US5613494A (en) 1997-03-25
JPH05178971A (ja) 1993-07-20
CA2069459A1 (en) 1992-11-25
NO302372B1 (no) 1998-02-23
US5505784A (en) 1996-04-09
EP0514790A2 (de) 1992-11-25

Similar Documents

Publication Publication Date Title
NO872248D0 (no) Fremgangsmaate for fremstilling av diperoksydodekandisyre-inneholdende agglomerater og preparater inneholdende disse som blekende bestanddel.
NO942835L (no) 1-benzensulfonyl-1,3-dihydro-2H-benzimidazol-2-on-derivater, fremstilling derav og farmasöytiske blandinger som inneholder dem
NO890921D0 (no) Fremgangsmaate for fremstilling av aminosyrederivater.
NO303638B1 (no) Kondenserte indolderivater, farmas°ytiske preparater inneholdende disse og anvendelse av derivatene
NO304774B1 (no) Tetrahydrokarbazolderivater, farmas÷ytiske blandinger inneholdende slike og anvendelse av disse derivater
NO922022L (no) Polykondensater som inneholder vinsyrederivater, fremgangsmaate for fremstilling av disse og anvendelse av dem
NO953367D0 (no) Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler
NO302368B1 (no) Kinoksalinforbindelser, farmasöytiske preparater som inneholder slike, og anvendelse av forbindelsene for fremstilling av preparatene
FI941447A0 (fi) Suun kautta annettavat, kapseleina olevat ubidekarenonivalmisteet
NO932998D0 (no) Nye 4,5-dihydro-4-okso-pyrrolo(1,2-a)kinoksaliner og tilsvarende aza-analoger og fremgangsmaate for fremstilling av dem
NO982754D0 (no) Fosfolipidderivater av fosfonokarboksylsyrer, fremstilling av slike derivater og anvendelse av derivatene som antivirusmedikamenter
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
NO166937C (no) Aromatiske naftylderivater for kosmetisk anvendelse og kosmetiske blandinger som inneholder dem.
NO860733L (no) N-(2-klor-4-trifluormethylfenyl)-3-trifluormethyl-benzensulfonamidderivat, fremgangsmaate for fremstilling av dette, og fungicid middel inneholdende dette.
DK635988D0 (da) 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater
NO903347L (no) 14,17alfa-ethano- og ethanooestratriener, fremgangsmaate forfremstilling av disse forbindelser, saavel som anvendelse av dem for fremstilling av legemidler.
DK90188D0 (da) Kombinationsprodukter indeholdende picolin- eller 2-pyridyloxyeddikesyre-derivater, praeparater omfattende saadanne produkter og anvendelse deraf som herbicider
NO882030D0 (no) Fremgangsmaate til fremstilling av hydrasinderivater til bruk som antihypertensivt middel.
NO883986L (no) Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.
NO860091L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 12-amino-pyridazino(4[,5[:3,4)pyrrolo(2,1-a)isokinolin-derivater.
NO910372D0 (no) Fremgangsmaate for fremstilling av heksahydropyrrolo(2,3-b)indolkarbamater-, urea-, amider og beslektede forbindelser og deres anvendelse som medikamenter.
NO885406L (no) Fremgangsmaate for fremstilling av 4-heteroaryl-1,3-benzodiazepiner og 2-substituerte-alfa-(hetero-aryl)benzenetanaminer og anvendelse derav som medikamenter.
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
NO891986D0 (no) Fremgangsmaate for fremstilling av difenyl-sulfider, difenyl-sulfoksyder og difenylsulfoner.
NO903967L (no) Dihydrocaffeinsyrederivater og farmasoeytiske preparater som inneholder disse.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2002